Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the addition of a full suite of ...

What Is the Immunohistochemistry Test? The immunohistochemistry (IHC) test can tell your cancer doctor (oncologist) whether you have certain types of breast cancer. Professionals in a lab check a ...

Immunohistochemistry uses antibodies to test tissue samples for specific types of antigens. It can often provide very specific results regarding cancer types or other diseases, helping doctors ...

Immunohistochemistry assay (IHC). This test uses a chemical dye to stain the HER2 proteins. It measures the amount of these proteins on the surface of the cells. Fluorescence in situ hybridization ...

The specific test within the report that determines your HER2 status is called an ImmunoHistoChemistry (IHC test), and it reveals to what extent your cancer cells have two types of receptor—HER2 ...

today announced that it has expanded its immunohistochemistry (IHC) test offerings to include MET IHC testing using the VENTANA® MET (SP44) RxDx assay, now available as an add-on to comprehensive ...

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications Agilent Technologies Inc. (NYSE: A) today ...

Using antibodies to detect specific proteins in tissue samples, Foundation Medicine’s IHC test offerings complement its CGP tests and together support healthcare providers to make well-informed ...

Foundation Medicine, Inc., a genomics company committed to transforming cancer care , today announced that it has expanded its immunohistochemistry (IHC) test offerings to include MET IHC testing ...